查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786872

伴随式诊断(CDx)开发市场，规模，占有率，趋势，产业分析报告:各服务形式，分析方法，各目标治疗领域，各终端用户，各地区，2025年～2034年的市场预测

Companion Diagnostics Development Market Size, Share, Trends, Industry Analysis Report By Type of Service, By Analytical Technique, By Target Therapeutic Area, By End User, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，全球伴随诊断 (CDx) 开发市场预计到 2034 年将达到 17.5579 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

伴随诊断 (CDx) 开发市场围绕着与特定治疗药物密切相关的专用诊断测试的研发和生产。这些测试对于提供关键资讯至关重要，有助于医疗保健专业人员确定哪些患者最有可能从特定治疗中受益。透过识别特定的生物标记和基因特征，CDx 可以确保个人化治疗，从而提高药物安全性和有效性，同时最大限度地降低副作用风险。这种药物和诊断方法共同开发的方式是精准医疗的基础，它推动医疗保健朝向更个人化、更有针对性的治疗方向发展。

随着全球对个人化医疗的追求以及疾病（尤其是癌症）日益复杂的现状，伴随诊断 (CDx) 开发市场正在经历强劲增长。随着更多标靶疗法的开发，对用于识别合格患者群体的伴随诊断 (CDx) 的需求也日益增长。分子生物学、基因组学和新一代定序 (NGS) 等分析技术的发展也推动了该领域的创新，使得新的生物标记物的发现和更精密的诊断工具的开发成为可能。监管机构在塑造伴随诊断 (CDx) 市场方面发挥关键作用，它们为伴随诊断 (CDx) 的联合开发和审批提供指导，进一步将这些诊断技术融入主流医疗实践。

伴随诊断 (CDx) 发展市场报告重点：

按服务类型划分，预计临床验证将在 2024 年占据最大市场占有率。这是因为它在证明诊断药物在真实患者环境中的有效性方面发挥着至关重要的作用。可靠的临床验证对于监管审批至关重要，并确保检测能够准确预测患者对特定药物的反应。

按分析方法划分，预计聚合酶炼式反应 (PCR) 将在 2024 年占据最大市场占有率。这是因为它可靠性高、成本效益高，并且在临床实验室中广泛使用。它在检测基因标靶方面具有高灵敏度和特异性，使其成为识别生物标记以指导标靶治疗的基础技术。

按目标治疗领域划分，预计肿瘤学将在2024年占据最大的市场占有率。这主要是因为各种癌症在全球范围内的高发病率以及个人化医疗在癌症治疗中的日益普及。伴随诊断对于筛选对特定癌症疗法反应最佳的患者至关重要。

按最终用户划分，由于在药物研发方面的大量投资以及与伴随诊断共同开发新型疗法的内在需求，行业参与者将在2024年占据显着占有率。产业参与者拥有丰富的资源和全球商业网络，使他们能够应对复杂的监管要求，从而促进伴随诊断的普及。

按地区划分，北美将在2024年占据伴随诊断市场的最大占有率，这得益于其先进的医疗基础设施、高昂的医疗成本以及鼓励快速采用新诊断技术的有利监管环境。

伴随诊断 (CDx) 开发市场包括罗氏公司 (F. Hoffmann-La Roche Ltd.)、凯杰公司 (QIAGEN N.V.)、安捷伦科技公司 (Agilent Technologies, Inc.)、雅培实验室 (Abbott Laboratories)、Illumina 公司、Myriad Genetics 公司、Sysbbott Laboratories)、Illumina 公司、Myriad Genetics 公司、Sysmex Genex、Thix 飞世科技公司 (TheMx Genetics" 公司、飞世科技公司、飞默科技公司、飞默科技公司 (TheMx Genetics" Inc.)、Labcorp、Quest Diagnostics 和 Guardant Health, Inc.。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球伴随式诊断(CDx)开发市场洞察

  • 市场概述
  • 伴随式诊断(CDx)开发市场动态
    • 促进因素和机会
      • 个人化医疗的普及率不断提高
      • 癌症发生率不断上升
    • 限制与课题
      • 复杂且冗长的共同开发与审批流程
  • PESTEL分析
  • 伴随式诊断(CDx)开发市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球伴随式诊断(CDx)开发市场:各服务形式

  • 主要调查结果
  • 简介
  • 可行性调查
  • 化验开发
  • 分析检验
  • 临床检验
  • 製造业

第6章 全球伴随式诊断(CDx)开发市场:各分析技术

  • 主要调查结果
  • 简介
  • NGS
  • PCR
  • IHC
  • 流式细胞技术
  • 其他

第7章 全球伴随式诊断(CDx)开发市场:各目标治疗领域

  • 主要调查结果
  • 简介
  • 肿瘤性疾病
  • 非肿瘤性疾病

第8章 全球伴随式诊断(CDx)开发市场:各终端用户

  • 主要调查结果
  • 简介
  • 产业企业
  • 产业外企业

第9章 全球伴随式诊断(CDx)开发市场:各地区

  • 主要调查结果
  • 简介
    • 伴随式诊断(CDx)开发市场评估:各地区，2020～2034年
  • 北美
    • 北美:各服务形式，2020～2034年
    • 北美:各分析技术，2020～2034年
    • 北美:各目标治疗领域，2020年～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各服务形式，2020～2034年
    • 欧洲:各分析技术，2020～2034年
    • 欧洲:各目标治疗领域，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各服务形式，2020～2034年
    • 亚太地区:各分析方法，2020～2034年
    • 亚太地区:各目标治疗领域，2020年～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各服务形式，2020～2034年
    • 中东·非洲:各分析方法，2020～2034年
    • 中东·非洲:各目标治疗领域，2020年～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各服务形式，2020～2034年
    • 南美:各分析方法，2020～2034年
    • 南美:各目标治疗领域，2020年～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Labcorp
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: PM5955

The global companion diagnostics (CDx) development market size is expected to reach USD 1,755.79 million by 2034, according to a new study by Polaris Market Research. The report "Companion Diagnostics (Cdx) Development Market Size, Share, Trends, Industry Analysis Report By Type of Service (Feasibility Studies, Assay Development), By Analytical Technique, By Target Therapeutic Area, By End User, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The companion diagnostics (CDx) development market revolves around the creation and production of specialized diagnostic tests that are intricately linked with specific therapeutic drugs. These tests are vital for providing crucial information that guides healthcare professionals in determining which patients are most likely to benefit from a particular treatment. By identifying specific biomarkers or genetic characteristics, CDx ensures that treatments are tailored to individual patients, thereby enhancing both the safety and effectiveness of medications while minimizing the risk of adverse reactions. This co-development approach between a drug and its diagnostic is a cornerstone of precision medicine, moving healthcare toward more personalized and targeted interventions.

The companion diagnostics development market is experiencing strong growth, driven by a global push toward personalized medicine and the increasing complexity of diseases, especially cancer. As more targeted therapies are developed, the demand for CDx to identify eligible patient populations continues to rise. Advancements in molecular biology, genomics, and analytical techniques such as next-generation sequencing (NGS) are also fueling innovation in this sector, allowing for the discovery of new biomarkers and the development of more sophisticated diagnostic tools. Regulatory agencies play a key role in shaping this market by providing guidelines for the co-development and approval of CDx, further integrating these diagnostics into mainstream medical practice.

Companion Diagnostics Development Market Report Highlights:

By type of service, the clinical validation segment held the largest share in 2024 due to its essential role in demonstrating a diagnostic's effectiveness in real-world patient settings. Robust clinical validation is critical for regulatory approval, ensuring the test accurately predicts patient response to a specific drug.

By analytical technique, the polymerase chain reaction (PCR) segment held the largest share in 2024 owing to its proven reliability, cost-effectiveness, and widespread use in clinical labs. Its high sensitivity and specificity in detecting genetic targets make it a fundamental technology for identifying biomarkers that guide targeted therapies.

By target therapeutic area, the oncological disorders segment held the largest share in 2024, primarily driven by the high global prevalence of various cancers and the increasing adoption of personalized medicine in cancer treatment. Companion diagnostics are vital for selecting patients who will best respond to specific cancer therapies.

By end user, the industry players segment held a larger share in 2024 due to their significant investments in drug discovery and their inherent need to co-develop CDx alongside new therapeutics. Their extensive resources and global commercial networks enable them to navigate complex regulatory requirements and drive CDx adoption.

By region, North America held the largest share of the global companion diagnostics market in 2024, benefiting from its advanced healthcare infrastructure, high healthcare spending, and a supportive regulatory environment that encourages the rapid adoption of new diagnostic technologies.

The companion diagnostics development market includes active players such as F. Hoffmann-La Roche Ltd.; QIAGEN N.V.; Agilent Technologies, Inc.; Abbott Laboratories; Illumina, Inc.; Myriad Genetics, Inc.; Sysmex Corporation; BioMerieux SA; Thermo Fisher Scientific Inc.; Labcorp; Quest Diagnostics; and Guardant Health, Inc.

Polaris Market Research has segmented the CDx development market report on the basis of type of service, analytical technique, target therapeutic area, end user, and region:

By Type of Service Outlook (Revenue - USD Million, 2020-2034)

Feasibility Studies

Assay Development

Analytical Validation

Clinical Validation

Manufacturing

By Analytical Technique Outlook (Revenue - USD Million, 2020-2034)

NGS

PCR

IHC

Flow Cytometry

Others

By Target Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

Oncological Disorders

Non-oncological Disorders

By End User Outlook (Revenue - USD Million, 2020-2034)

Industry Players

Non-Industry Players

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Companion Diagnostics (Cdx) Development Market Insights

  • 4.1. Companion Diagnostics (Cdx) Development Market - Market Snapshot
  • 4.2. Companion Diagnostics (Cdx) Development Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Personalized Medicine
      • 4.2.1.2. Rising Incidence of Cancer
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex and lengthy co-development and approval processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Companion Diagnostics (Cdx) Development Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Companion Diagnostics (Cdx) Development Market, by Type of Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • 5.3. Feasibility Studies
    • 5.3.1. Global Companion Diagnostics (Cdx) Development Market, by Feasibility Studies, by Region, 2020-2034 (USD Million)
  • 5.4. Assay Development
    • 5.4.1. Global Companion Diagnostics (Cdx) Development Market, by Assay Development, by Region, 2020-2034 (USD Million)
  • 5.5. Analytical Validation
    • 5.5.1. Global Companion Diagnostics (Cdx) Development Market, by Analytical Validation, by Region, 2020-2034 (USD Million)
  • 5.6. Clinical Validation
    • 5.6.1. Global Companion Diagnostics (Cdx) Development Market, by Clinical Validation, by Region, 2020-2034 (USD Million)
  • 5.7. Manufacturing
    • 5.7.1. Global Companion Diagnostics (Cdx) Development Market, by Manufacturing, by Region, 2020-2034 (USD Million)

6. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • 6.3. NGS
    • 6.3.1. Global Companion Diagnostics (Cdx) Development Market, by NGS, by Region, 2020-2034 (USD Million)
  • 6.4. PCR
    • 6.4.1. Global Companion Diagnostics (Cdx) Development Market, by PCR, by Region, 2020-2034 (USD Million)
  • 6.5. IHC
    • 6.5.1. Global Companion Diagnostics (Cdx) Development Market, by IHC, by Region, 2020-2034 (USD Million)
  • 6.6. Flow Cytometry
    • 6.6.1. Global Companion Diagnostics (Cdx) Development Market, by Flow Cytometry, by Region, 2020-2034 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Companion Diagnostics (Cdx) Development Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • 7.3. Oncological Disorders
    • 7.3.1. Global Companion Diagnostics (Cdx) Development Market, by Oncological Disorders, by Region, 2020-2034 (USD Million)
  • 7.4. Non-oncological Disorders
    • 7.4.1. Global Companion Diagnostics (Cdx) Development Market, by Non-oncological Disorders, by Region, 2020-2034 (USD Million)

8. Global Companion Diagnostics (Cdx) Development Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 8.3. Industry Players
    • 8.3.1. Global Companion Diagnostics (Cdx) Development Market, by Industry Players, by Region, 2020-2034 (USD Million)
  • 8.4. Non-Industry Players
    • 8.4.1. Global Companion Diagnostics (Cdx) Development Market, by Non-Industry Players, by Region, 2020-2034 (USD Million)

9. Global Companion Diagnostics (Cdx) Development Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Companion Diagnostics (Cdx) Development Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Companion Diagnostics (Cdx) Development Market - North America
    • 9.3.1. North America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.3.2. North America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.3.3. North America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.3.4. North America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.3.5. Companion Diagnostics (Cdx) Development Market - US
      • 9.3.5.1. US: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.3.5.2. US: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.3.5.3. US: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.3.5.4. US: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.3.6. Companion Diagnostics (Cdx) Development Market - Canada
      • 9.3.6.1. Canada: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.4. Companion Diagnostics (Cdx) Development Market - Europe
    • 9.4.1. Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.4.2. Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.4.3. Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.4.4. Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.5. Companion Diagnostics (Cdx) Development Market - UK
      • 9.4.5.1. UK: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.6. Companion Diagnostics (Cdx) Development Market - France
      • 9.4.6.1. France: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.6.2. France: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.6.3. France: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.6.4. France: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.7. Companion Diagnostics (Cdx) Development Market - Germany
      • 9.4.7.1. Germany: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.8. Companion Diagnostics (Cdx) Development Market - Italy
      • 9.4.8.1. Italy: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.9. Companion Diagnostics (Cdx) Development Market - Spain
      • 9.4.9.1. Spain: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.10. Companion Diagnostics (Cdx) Development Market - Netherlands
      • 9.4.10.1. Netherlands: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.11. Companion Diagnostics (Cdx) Development Market - Russia
      • 9.4.11.1. Russia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.4.12. Companion Diagnostics (Cdx) Development Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.5. Companion Diagnostics (Cdx) Development Market - Asia Pacific
    • 9.5.1. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.5. Companion Diagnostics (Cdx) Development Market - China
      • 9.5.5.1. China: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.5.2. China: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.5.3. China: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.5.4. China: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.6. Companion Diagnostics (Cdx) Development Market - India
      • 9.5.6.1. India: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.6.2. India: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.6.3. India: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.6.4. India: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.7. Companion Diagnostics (Cdx) Development Market - Malaysia
      • 9.5.7.1. Malaysia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.8. Companion Diagnostics (Cdx) Development Market - Japan
      • 9.5.8.1. Japan: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.9. Companion Diagnostics (Cdx) Development Market - Indonesia
      • 9.5.9.1. Indonesia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.10. Companion Diagnostics (Cdx) Development Market - South Korea
      • 9.5.10.1. South Korea: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.11. Companion Diagnostics (Cdx) Development Market - Australia
      • 9.5.11.1. Australia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.5.12. Companion Diagnostics (Cdx) Development Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.6. Companion Diagnostics (Cdx) Development Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.5. Companion Diagnostics (Cdx) Development Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.6. Companion Diagnostics (Cdx) Development Market - UAE
      • 9.6.6.1. UAE: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.7. Companion Diagnostics (Cdx) Development Market - Israel
      • 9.6.7.1. Israel: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.8. Companion Diagnostics (Cdx) Development Market - South Africa
      • 9.6.8.1. South Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.6.9. Companion Diagnostics (Cdx) Development Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • 9.7. Companion Diagnostics (Cdx) Development Market - Latin America
    • 9.7.1. Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.5. Companion Diagnostics (Cdx) Development Market - Mexico
      • 9.7.5.1. Mexico: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.6. Companion Diagnostics (Cdx) Development Market - Brazil
      • 9.7.6.1. Brazil: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.7. Companion Diagnostics (Cdx) Development Market - Argentina
      • 9.7.7.1. Argentina: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
    • 9.7.8. Companion Diagnostics (Cdx) Development Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BioMerieux SA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. F. Hoffmann-La Roche Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Guardant Health, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Illumina, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Labcorp
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Myriad Genetics, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. QIAGEN N.V.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Quest Diagnostics
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Sysmex Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Thermo Fisher Scientific Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 2 Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 3 Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 4 Global Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 5 North America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 6 North America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 7 North America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 8 North America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 9 U.S.: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 10 U.S.: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 11 U.S.: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 12 U.S.: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 13 Canada: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 14 Canada: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 15 Canada: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 16 Canada: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 17 Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 18 Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 19 Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 20 Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 21 UK: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 22 UK: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 23 UK: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 UK: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 25 France: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 26 France: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 27 France: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 28 France: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 29 Germany: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 30 Germany: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 31 Germany: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 32 Germany: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 33 Italy: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 34 Italy: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 35 Italy: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 36 Italy: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 37 Spain: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 38 Spain: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 39 Spain: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 40 Spain: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 41 Netherlands: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 42 Netherlands: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 43 Netherlands: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 44 Netherlands: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 45 Russia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 46 Russia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 47 Russia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 48 Russia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 49 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 50 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 51 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 52 Rest of Europe: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 53 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 54 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 55 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 56 Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 57 China: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 58 China: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 59 China: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 60 China: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 61 India: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 62 India: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 63 India: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 64 India: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 65 Malaysia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 66 Malaysia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 67 Malaysia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 68 Malaysia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 69 Japan: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 70 Japan: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 71 Japan: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 72 Japan: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 73 Indonesia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 74 Indonesia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 75 Indonesia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 76 Indonesia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 77 South Korea: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 78 South Korea: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 79 South Korea: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 80 South Korea: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 81 Australia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 82 Australia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 83 Australia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Australia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 85 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 86 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 87 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 88 Rest of Asia Pacific: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 89 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 90 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 91 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 92 Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 93 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 94 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 95 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 96 Saudi Arabia: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 97 UAE: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 98 UAE: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 99 UAE: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 100 UAE: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 101 Israel: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 102 Israel: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 103 Israel: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 104 Israel: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 105 South Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 106 South Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 107 South Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 108 South Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 109 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 110 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 111 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 112 Rest of Middle East & Africa: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 113 Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 114 Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 115 Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 116 Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 117 Mexico: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 118 Mexico: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 119 Mexico: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 120 Mexico: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 121 Brazil: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 122 Brazil: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 123 Brazil: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 124 Brazil: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 125 Argentina: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 126 Argentina: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 127 Argentina: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 128 Argentina: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)
  • Table 129 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Type of Service, 2020-2034 (USD Million)
  • Table 130 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2020-2034 (USD Million)
  • Table 131 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2020-2034 (USD Million)
  • Table 132 Rest of Latin America: Companion Diagnostics (Cdx) Development Market, by End User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Companion Diagnostics (Cdx) Development Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type of Service
  • Figure 7. Global Companion Diagnostics (Cdx) Development Market, by Type of Service, 2024 & 2034 (USD Million)
  • Figure 8. Market by Analytical Technique
  • Figure 9. Global Companion Diagnostics (Cdx) Development Market, by Analytical Technique, 2024 & 2034 (USD Million)
  • Figure 10. Market by Target Therapeutic Area
  • Figure 11. Global Companion Diagnostics (Cdx) Development Market, by Target Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 12. Market by End User
  • Figure 13. Global Companion Diagnostics (Cdx) Development Market, by End User, 2024 & 2034 (USD Million)